A case of probable neuroleptic malignant syndrome induced by monotherapy with paroxetine
Nishimura, H.; Kashima, N.
Seishin Shinkeigaku Zasshi 106(6): 723-726
2004
ISSN/ISBN: 0033-2658 PMID: 15387267 Document Number: 573860
Document emailed within 1 workday
Related Documents
Hamada, Y.; Miyamoto, K.; Inatsugi, Y.; Suzuki, H.; Kusunoki, S. 2006: A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine Rinsho Shinkeigaku 46(8): 575-578DasGupta, K.; Young, A. 1991: Clozapine-induced neuroleptic malignant syndrome Journal of Clinical Psychiatry 52(3): 105-107
Fernández, M.; Lago, L.; Alonso, M.Gema.; Guede, A.; Benavente, J.Luis.; Olivares, J.M. 2018: Serotonin syndrome versus neuroleptic malignant syndrome: a case report Actas Espanolas de Psiquiatria 46(2): 68-74
Roca, B.; Sáez-Royuela, A.; Suay, A.; Simón, E. 1997: Neuroleptic malignant syndrome: report of a case Anales de Medicina Interna 14(3): 155
Samar, R.K.; Kaushik, S.K.; Garg, A.R. 1983: Malignant neuroleptic syndrome due to haloperidol. (A case report) Journal of Postgraduate Medicine 29(1): 56-58
Moltz, D.A.; Coeytaux, R.R. 1998: Case report: possible neuroleptic malignant syndrome associated with olanzapine Journal of Clinical Psychopharmacology 18(6): 485-486
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Wäger, O.; Hell, D. 1988: Malignant neuroleptic syndrome. Literature review and case report Schweizerische Medizinische Wochenschrift 118(1): 27-31
McCarron, M.M.; Boettger, M.L.; Peck, J.J. 1982: A case of neuroleptic malignant syndrome successfully treated with amantadine Journal of Clinical Psychiatry 43(9): 381-382
Revuelta, E.; Bordet, R.; Piquet, T.; Ghawche, F.; Destee, A.; Goudemand, M. 1994: Acute catatonia and neuroleptic malignant syndrome. a case of infantile psychosis L'Encephale 20(3): 351-354
Terlikowska, M.; Marzański, M. 1995: Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report Psychiatria Polska 29(3): 343-348
Chen, C.C.; Chen, S.S.; Wen, J.K. 1985: Neuroleptic malignant syndrome and myopathy: a case report of lithium and haloperidol intoxication Journal of the Formosan Medical Association 84(12): 1371-1379
Sule, A.; Gohar, S.; Mittal, G.; Balakrishnan, C.; Mangat, G.; Joshi, V.R. 2000: Neuroleptic malignant syndrome occurring in a suspected case of systemic lupus erythematosus Journal of the Association of Physicians of India 48(4): 437-438
Lambrecht, E.R.; Meems, B.J. 1987: A case of neuroleptic malignant syndrome with myoglobinuric acute renal failure treated with dialysis and levodopa Netherlands Journal of Medicine 30(1-2): 80-84
Tsai, M-Chang.; Huang, T-Lai. 2010: Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report Chang Gung Medical Journal 33(5): 576-580
Bidzińska, E. 1986: Malignant neuroleptic syndrome Psychiatria Polska 20(6): 483-488
Retamal, P. 1990: Neuroleptic malignant syndrome Revista Medica de Chile 118(6): 679-685
Kishida, I.; Furuno, T.; Kawanishi, C. 2012: Neuroleptic malignant syndrome (NMS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 612-615
Segado Soriano, A.; López Gonzalez-Cobos, C.; Villalba Garciá, M.V.; Gil Gómez, J.; Muiño Miguez, A.; Millan Núñez-Cortés, J. 1997: Malignant neuroleptic syndrome Anales de Medicina Interna 14(5): 231-235
Courtine, J.C.; Blot, P. 1981: Malignant neuroleptic syndrome La Nouvelle Presse Medicale 10(21): 1749